Astera Labs, Inc. (ALAB) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +12.75%. A quarter ago, it was expected that this company would post earnings of $0.39 per share wh...
Astera Labs, Inc. (ALAB) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +12.75%. A quarter ago, it was expected that this company would post earnings of $0.39 per share when it actually produced earnings of $0.49, delivering a surprise of +25.64%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Astera Labs, Inc., which belongs to the Zacks Internet - Software industry, posted revenues of $270.58 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 8.33%. This compares to year-ago revenues of $141.1 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Astera Labs, Inc. shares have added about 12.8% since the beginning of the year versus the S&P 500's gain of 1.7%. What's Next for Astera Labs, Inc.? While Astera Labs, Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earn...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on W. P. Carey W. P. Carey Vs. Gladstone Commercial: Which Is The Best REIT? W. P. Carey: Exposure To Europe Is A Key Competitive Advantage W. P. Carey: Sleep Well At Night With This 6% Yield W.P. Carey Q4 earnings shine, helped by strong investment volume W. P. Carey FFO of $1.27 beats by $0.03, revenue of $444.55M beats by $11.27M
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on W. P. Carey W. P. Carey Vs. Gladstone Commercial: Which Is The Best REIT? W. P. Carey: Exposure To Europe Is A Key Competitive Advantage W. P. Carey: Sleep Well At Night With This 6% Yield W.P. Carey Q4 earnings shine, helped by strong investment volume W. P. Carey FFO of $1.27 beats by $0.03, revenue of $444.55M beats by $11.27M
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up here . They’ve already put up signs in metro Detroit directing travelers how to get to the Gordie Howe International Bridge, the new cable-stayed crossing that stretches from America’s automotive capital across the river to Windsor, Ontario. ...
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up here . They’ve already put up signs in metro Detroit directing travelers how to get to the Gordie Howe International Bridge, the new cable-stayed crossing that stretches from America’s automotive capital across the river to Windsor, Ontario. The two cities are connected not just by bridges and tunnels but by culture, history, industry and sport. (Just drop in on a Windsor sports bar when the Detroit Red Wings are playing a big game. You’ll see.) The Ontario-Michigan link is so economically important that Canada agreed to pay all of the costs of the Gordie Howe, some C$6.4 billion ($4.7 billion), to smooth trade flows. After many years of slogging, and the usual cost overruns, the crossing is basically ready . The deal is this: The Canadian government pays for the bridge, both sides get construction jobs, and Canada receives toll revenues until it recoups its costs. After that, it shares the proceeds with Michigan. So President Donald Trump surprised and confused many when he posted on Monday night that he wouldn’t allow the new bridge to open until the US was “fully compensated” and Canada gives the US “the Fairness and Respect that we deserve.” The US should own at least 50% of the bridge, he said. White House Press Secretary Karoline Leavitt reinforced that, stating this afternoon that Trump also believes the US should “have shared authority over what passes across it, and participate in the economic benefits generated by its use.” This, too, was confusing. The state of Michigan shares ownership of the bridge with Canada. The bridge has an “international authority” with six members , three appointed by Michigan and three by Canada. And the tolls are to be split once Canada’s costs are repaid, according to a spokesperson for the Canadian infrastructure minister. Prime Minister Mark Carney told reporters he exp...
(RTTNews) - Centrus Energy Corp. (LEU) announced earnings for fourth quarter that Dropped, from last year The company's earnings came in at $17.8 million, or $0.79 per share. This compares with $53.7 million, or $3.20 per share, last year. The company's revenue for the period fell 3.6% to $146.2 million from $151.6 million last year. Centrus Energy Corp. earnings at a glance (GAAP) : -Earnings: $1...
(RTTNews) - Centrus Energy Corp. (LEU) announced earnings for fourth quarter that Dropped, from last year The company's earnings came in at $17.8 million, or $0.79 per share. This compares with $53.7 million, or $3.20 per share, last year. The company's revenue for the period fell 3.6% to $146.2 million from $151.6 million last year. Centrus Energy Corp. earnings at a glance (GAAP) : -Earnings: $17.8 Mln. vs. $53.7 Mln. last year. -EPS: $0.79 vs. $3.20 last year. -Revenue: $146.2 Mln vs. $151.6 Mln last year. Financial 2026 Outlook : Total revenue to be in the range of $425 million to $475 million The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
SlavkoSereda/iStock via Getty Images Kyndryl ( KD ) is a company that caught my interest some time ago, it being a peer of Globant ( GLOB ), a company that I also cover. Then, when the company dropped more than 54% in trading yesterday, I took that as a sign to look at the cause, the underlying logic, and the upside (and downside potential) of the stock. Typically, whenever the market gives that s...
SlavkoSereda/iStock via Getty Images Kyndryl ( KD ) is a company that caught my interest some time ago, it being a peer of Globant ( GLOB ), a company that I also cover. Then, when the company dropped more than 54% in trading yesterday, I took that as a sign to look at the cause, the underlying logic, and the upside (and downside potential) of the stock. Typically, whenever the market gives that sort of reaction, it is not outside the realm of possibility to expect this to be an overreaction. This, by the way, goes for companies swinging to the upside as well. Valuation overreactions go both ways - and this is one of the key market inefficiencies that I take advantage of in my investing. I will first look at what Kyndryl does, what differs (and what similarities there are as well) from Globant and other peers, and what sort of appeal we have. First, we can establish that this company has absolutely no yield. I also don't believe it, based on company history and management, to be likely to have a yield in the future. It is not an "old" company, meaning it has very little history, and it currently carries a market capitalization of about $2.4B. Despite this, the company does have an IG rating on the low side, at BBB- (probably due to it being a former part of a giant business). This is impressive. Also, if you're taking the company's earnings and forecasts as a bit of gospel, the company is trading at a relatively compelling EPS multiple. Of course, one of the issues with the IT sector as a whole, and AI and data right now, is the speculation laced in these companies - it means that I don't give much for AEPS estimates from players that have neither the history nor any likely future reasons to expect this. But let's see what Kyndryl offers us. Kyndryl: What Upside Is There After a 50% Drop in 2026E. The similarities between Kyndryl and Globant are bigger than the differences if you take a high-level view. Both are in IT services, and although they operate in very diff...
In what is set to be its most audacious anti-environment move yet, the Trump administration on Thursday will roll back the mechanism allowing the government to regulate planet-heating pollution, the White House press secretary has told reporters. “President Trump will be joined by EPA Administrator Lee Zeldin to formalize the recession of the 2009 Obama-era endangerment finding,” Karoline Leavitt ...
In what is set to be its most audacious anti-environment move yet, the Trump administration on Thursday will roll back the mechanism allowing the government to regulate planet-heating pollution, the White House press secretary has told reporters. “President Trump will be joined by EPA Administrator Lee Zeldin to formalize the recession of the 2009 Obama-era endangerment finding,” Karoline Leavitt said at a press conference on Tuesday. “This will be the largest deregulatory action in American history.” The finding determined that CO2 and other greenhouse gases endanger public health and welfare, establishing a legal basis to regulate them under the Clean Air Act. Its overturning will be a “devastating blow to millions of Americans facing growing risks of unnatural disasters”, said Meredith Hankins, federal climate legal director at the environmental advocacy non-profit National Resources Defense Council. “The Trump EPA is cynically pretending climate change isn’t a risk to Americans’ health and welfare,” said Hankins. “This is the biggest attack ever on federal authority to tackle the climate crisis. The rollback is sure to draw legal challenges. “This isn’t going to stand without a fight,” Hankins added. “The EPA’s slapdash legal arguments should be laughed out of court. We will be seeing them in court – and we are going to win.” The Environmental Defense Fund has also promised to sue EPA over the rule, said Fred Krupp, its president. Abigail Dillen, president of green legal organization Earthjustice, also said her group “will see the Trump administration in court”. In a statement, an EPA spokesperson called the endangerment finding “one of the most damaging decisions in modern history” and said “hardworking families and small businesses have paid the price” for it. “EPA is actively working to deliver a historic action for the American people,” the spokesperson said. Trump signed an executive order on his first day back in office directing EPA to assess whether the ...
watch now VIDEO 1:11 01:11 Lyft announces new $1 billion share repurchase program Closing Bell: Overtime Lyft 's stock tumbled 15% in extended trading on Tuesday after the ride-sharing company posted disappointing fourth-quarter results. Here how the company did versus LSEG estimates: Earnings per share : Not comparable Revenue : $1.59 billion vs. $1.76 billion Revenue grew 3% from a year ago. Boo...
watch now VIDEO 1:11 01:11 Lyft announces new $1 billion share repurchase program Closing Bell: Overtime Lyft 's stock tumbled 15% in extended trading on Tuesday after the ride-sharing company posted disappointing fourth-quarter results. Here how the company did versus LSEG estimates: Earnings per share : Not comparable Revenue : $1.59 billion vs. $1.76 billion Revenue grew 3% from a year ago. Bookings grew 19% year over year to $5.07 billion, which was in line with Wall Street estimates. Net income totaled about $2.76 billion, or $6.72 per share. The company said it expects adjusted earnings before interest, taxes, depreciation and amortization, a measure of profitability, to range between $120 million and $140 million in the current quarter. Analysts expected $139.8 million for the current period. Lyft said that recent legislation, which cut insurance costs in California, contributed to lower rideshare prices. "While we expect this to drive increased demand over time, broad-based consumer adoption will take time to materialize and we now anticipate this being back-half weighted," the company said in a release. Lyft posted lackluster ride metrics for the fourth quarter. Active riders totaled 29.2 million during the period and came up short of a StreetAccount estimate of 29.5 million. Rides totaled 243.5 million, versus a FactSet estimate of 256.6 million. The company's board also approved up to $1 billion in additional share buybacks. Read more CNBC tech news 'Impossible': Taiwan pushes back against Washington's 40% chip supply relocation goal Alphabet calls out new AI-related risks, as it taps debt market to fund build-out Tesla exec Raj Jegannathan leaves automaker after 13 years Short seller CapitalWatch apologizes, retracts report on AppLovin shareholder
Earnings Call Insights: Canaan Inc. (CAN) Q4 2025 Management View CEO Nangeng Zhang reported that Canaan achieved "our highest quarterly revenue in the past 3 years and exceeded the midpoint of our guidance range of USD 175 million to USD 205 million." Zhang highlighted a "major breakthrough in mining machine sales" driven by a large-scale order of over 50,000 A15 Pro models from a leading North A...
Earnings Call Insights: Canaan Inc. (CAN) Q4 2025 Management View CEO Nangeng Zhang reported that Canaan achieved "our highest quarterly revenue in the past 3 years and exceeded the midpoint of our guidance range of USD 175 million to USD 205 million." Zhang highlighted a "major breakthrough in mining machine sales" driven by a large-scale order of over 50,000 A15 Pro models from a leading North American miner and noted the company's "all-time high of 14.6 exahash per second in computing power sold during the quarter, up 45.7% quarter-over-quarter and 60.9% year-over-year." Zhang detailed the expansion of self-mining operations and diversification through "several pilot projects," with 300 Bitcoins mined in the quarter and a year-end crypto asset holding of 1,750 Bitcoins and 3,951 Ethereum. He emphasized the company's entry into energy infrastructure, referencing a Canadian project converting flared natural gas into computing power and the official launch of the A16XP air-cooled model with "over 300 terahash per second per unit with an industry-leading power efficiency of 12.8 joules per terahash." Zhang outlined a 2026 strategy focused on "two core pillars": scaling power and computing infrastructure (with a shift from asset-light to systematic upstream development) and a deliberate, channel-driven approach to the consumer and SMB market. The primary objective is to "establish a pipeline of executable projects and clear development pathways" while maintaining "capital discipline." Zhang provided Q1 2026 revenue guidance, stating, "we expect total revenue for the first quarter of 2026 to be in the range of USD 60 million to USD 70 million." CFO James Cheng stated, "In Q4, we delivered $196 million in total revenue, up 30.4% sequentially and 121.1% year-over-year." Cheng added, "Revenue from North American customers reached $125 million, accounting for over 75% of our total product sales." Cheng addressed margin compression: "In Q4, our gross margin (sic) [gross pro...
Sundry Photography/iStock Editorial via Getty Images Introduction DuPont de Nemours, Inc. ( DD ) recently reported Q4 earnings that pleased investors; however, the company’s prospects right now aren’t too impressive, so I would like to see how the new, leaner DuPont performs over the next few quarters before I buy into it. By The Numbers Sales for the last quarter of the year were $1.69B, down 1% ...
Sundry Photography/iStock Editorial via Getty Images Introduction DuPont de Nemours, Inc. ( DD ) recently reported Q4 earnings that pleased investors; however, the company’s prospects right now aren’t too impressive, so I would like to see how the new, leaner DuPont performs over the next few quarters before I buy into it. By The Numbers Sales for the last quarter of the year were $1.69B, down 1% y/y, and beat estimates by $9m, essentially in line with estimates. Looking at the breakdown of revenue segments in more detail, Healthcare & Water Technologies sales came in at $821m, up around 4% y/y, and Diversified Industrials decreased 3% to $872m due to headwinds from the order timing shift into the third quarter. So, the laggard was the Diversified Industrials segment. Looking at the company’s profitability, Q4 Non-GAAP EPS came in at $0.46, which beat estimates by 3 cents. Operating margin for H&WT came in flat at 31.1%, and for Diversified Industrials, operating margins improved by 110 bps to 22.6%, which led to overall margin improvements to 24.2%, up 80 bps for the quarter. DD 8-K The company made a loss for the year, with -$779m in net loss, due to the company separating earlier in 2025. For the full year, however, if we look at adjusted numbers, the company made $1.68 in EPS and $0.21 (GAAP) EPS from continuing operations. So, overall, the company is still profitable if we take out the non-cash charges. Let’s take a look at the company’s financial position . DD finished the year with around $715m in cash and equivalents, against $3.1B in long-term debt. Is it worrisome? It probably looks like it will be this time around; the company didn’t turn a profit this quarter; however, if we look at the company’s adjusted numbers, as that seems to be the reality of what the company makes, the interest coverage ratio was around 7x if we look at operating EBITDA numbers. The company’s cash flow for the year was $560m, and free cash flow came in at $227m. Both are lower com...
This iconic but aging technology outfit is now squarely in the midst of the artificial intelligence revolution and perhaps better positioned than most of its AI peers. Most investors looking to capitalize on the artificial intelligence (AI) craze start their search with a familiar name like Nvidia, Microsoft, or Alphabet. And understandably so. These companies are not only advancing AI technology ...
This iconic but aging technology outfit is now squarely in the midst of the artificial intelligence revolution and perhaps better positioned than most of its AI peers. Most investors looking to capitalize on the artificial intelligence (AI) craze start their search with a familiar name like Nvidia, Microsoft, or Alphabet. And understandably so. These companies are not only advancing AI technology but monetizing it more than most other outfits. There's a largely overlooked AI outfit, however, that's just now coming into its own and could readily outperform the industry's more popular picks. That name? International Business Machines (IBM 0.98%). You know it better as IBM. Yes, that IBM That's not a typo. Most people may not realize it, but IBM is very much in the artificial intelligence business. It's just in it in a way that doesn't look like what most people think of when they think of AI. Chief among these differences is that it doesn't offer a consumer-facing platform like OpenAI's ChatGPT or Google's Gemini. Most of its tools are built for business purposes, like automation or AI-powered customer service agents. The other big difference is how it offers these solutions. Unlike Nvidia, which largely focuses on processor chips, or Alphabet's Google, which simply provides cloud-based access to its AI platform, IBM sells and then services entire mainframe computers capable of handling AI work, giving its customers the flexibility that can only come with ownership of such equipment. It's the business model that makes IBM a great pick It's not just high-performance hardware that makes IBM a compelling AI prospect, though. In fact, infrastructure only accounts for about one-fourth of its total business. It's what sales of these physical platforms also do that's so noteworthy. See, they also require IBM-coded software to operate, and they often require ongoing IBM-provided consulting work as well. These two offerings make up another one-fourth and nearly half (respectiv...
(RTTNews) - Astera Labs Inc. (ALAB) released earnings for its fourth quarter that Increases, from the same period last year The company's bottom line totaled $44.98 million, or $0.25 per share. This compares with $24.71 million, or $0.14 per share, last year. Excluding items, Astera Labs Inc. reported adjusted earnings of $104.76 million or $0.58 per share for the period. The company's revenue for...
(RTTNews) - Astera Labs Inc. (ALAB) released earnings for its fourth quarter that Increases, from the same period last year The company's bottom line totaled $44.98 million, or $0.25 per share. This compares with $24.71 million, or $0.14 per share, last year. Excluding items, Astera Labs Inc. reported adjusted earnings of $104.76 million or $0.58 per share for the period. The company's revenue for the period rose 91.8% to $270.58 million from $141.09 million last year. Astera Labs Inc. earnings at a glance (GAAP) : -Earnings: $44.98 Mln. vs. $24.71 Mln. last year. -EPS: $0.25 vs. $0.14 last year. -Revenue: $270.58 Mln vs. $141.09 Mln last year. -Guidance: Next quarter EPS guidance: $ 0.53 To $ 0.54 Next quarter revenue guidance: $ 286 M To $ 297 M The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The company had a record-setting fourth quarter, but that was nothing new. The stock of advanced medical devices maker Iradimed (IRMD +9.56%) was the very picture of health on Tuesday. The company released its latest earnings report, which revealed that -- for the 18th quarter in a row -- it set a new all-time high revenue figure. Also, both the top and bottom lines rose at double-digit rates. Inv...
The company had a record-setting fourth quarter, but that was nothing new. The stock of advanced medical devices maker Iradimed (IRMD +9.56%) was the very picture of health on Tuesday. The company released its latest earnings report, which revealed that -- for the 18th quarter in a row -- it set a new all-time high revenue figure. Also, both the top and bottom lines rose at double-digit rates. Investors rewarded this by trading the stock up by nearly 10% that day. Yet another peak In its fourth quarter of 2025, Iradimed earned $22.7 million in revenue, a 17% improvement over the same period of 2024. Net income not in accordance with generally accepted accounting practices (GAAP) flew higher, rising 23% to just under $7 million ($0.54 per share). With that bottom-line figure, Iradimed notched the latest in a series of beats on the consensus analyst estimate, which in this instance was $0.48 per share. The average pundit projection for revenue wasn't immediately available. The company, which specialized in intravenous infusion pump systems and monitoring systems designed to work with magnetic resonance imaging (MRI) procedures, benefited from the rollout of a new product. This is the 3870 intravenous infusion pump, which the company began shipping during the quarter. Iradimed also announced a dividend raise in its earnings release. The company's quarterly payout is to rise from $0.17 per share to $0.20, effective with the next distribution. This will take place on March 6 for investors of record as of Feb. 23. Expand NASDAQ : IRMD Iradimed Corporation Today's Change ( 9.56 %) $ 9.18 Current Price $ 105.15 Key Data Points Market Cap $1.2B Day's Range $ 99.32 - $ 107.90 52wk Range $ 47.23 - $ 107.90 Volume 132K Avg Vol 76K Gross Margin 77.07 % Dividend Yield 0.70 % More growth in store? Iradimed also proffered guidance for the entirety of 2026. It's estimating that revenue will come in at $91 million to $96 million, filtering down into non-GAAP (adjusted) net income of ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Advanced Micro Devices (NasdaqGS:AMD) has appointed Ariel Kelman as Senior Vice President and Chief Marketing Officer. Kelman, who has experience at Salesforce, Oracle, and AWS, will focus on AI and enterprise marketing as AMD s...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Advanced Micro Devices (NasdaqGS:AMD) has appointed Ariel Kelman as Senior Vice President and Chief Marketing Officer. Kelman, who has experience at Salesforce, Oracle, and AWS, will focus on AI and enterprise marketing as AMD scales its data center and AI offerings. For you as an investor following NasdaqGS:AMD, this move sits at the intersection of chips and cloud. AMD is pushing deeper into data center and AI with products such as EPYC server processors and the MI450 AI accelerator, while competing for mindshare with large tech and semiconductor peers. Having a CMO with enterprise cloud and AI experience is intended to help the company communicate its product lineup more clearly to large customers. Kelman’s background with major cloud and software platforms may matter as AMD works with prominent AI and cloud partners on new deployments. As the company highlights its ambitions for AI and data center in recent product and earnings updates, investors may watch how its messaging, customer outreach, and partner activity evolve under this new marketing leadership. Stay updated on the most important news stories for Advanced Micro Devices by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Advanced Micro Devices. NasdaqGS:AMD 1-Year Stock Price Chart How Advanced Micro Devices stacks up against its biggest competitors Kelman’s appointment comes after a year where AMD’s data center and AI story has been front and center, with products like EPYC server chips and Instinct AI accelerators featuring heavily in earnings calls and partner announcements. For you, the key question is whether an AI focused CMO with Salesforce, Oracle and Amazon Web Services experience can help AMD translate those technical products into clearer value propositions for...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Advanced Micro Devices (NasdaqGS:AMD) has appointed Ariel Kelman as Senior Vice President and Chief Marketing Officer. Kelman, who has experience at Salesforce, Oracle, and AWS, will focus on AI and enterprise marketing as AMD s...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Advanced Micro Devices (NasdaqGS:AMD) has appointed Ariel Kelman as Senior Vice President and Chief Marketing Officer. Kelman, who has experience at Salesforce, Oracle, and AWS, will focus on AI and enterprise marketing as AMD scales its data center and AI offerings. For you as an investor following NasdaqGS:AMD, this move sits at the intersection of chips and cloud. AMD is pushing deeper into data center and AI with products such as EPYC server processors and the MI450 AI accelerator, while competing for mindshare with large tech and semiconductor peers. Having a CMO with enterprise cloud and AI experience is intended to help the company communicate its product lineup more clearly to large customers. Kelman’s background with major cloud and software platforms may matter as AMD works with prominent AI and cloud partners on new deployments. As the company highlights its ambitions for AI and data center in recent product and earnings updates, investors may watch how its messaging, customer outreach, and partner activity evolve under this new marketing leadership. Stay updated on the most important news stories for Advanced Micro Devices by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Advanced Micro Devices. NasdaqGS:AMD 1-Year Stock Price Chart How Advanced Micro Devices stacks up against its biggest competitors Kelman’s appointment comes after a year where AMD’s data center and AI story has been front and center, with products like EPYC server chips and Instinct AI accelerators featuring heavily in earnings calls and partner announcements. For you, the key question is whether an AI focused CMO with Salesforce, Oracle and Amazon Web Services experience can help AMD translate those technical products into clearer value propositions for...
filo/iStock via Getty Images Although its Q4 2025 results beat on both lines, Gilead Sciences ( GILD ) is down ~4% in after-hours trading Tuesday after posting 2026 EPS guidance range with the midpoint below the consensus. The biopharma is predicting 2026 non-GAAP EPS of $8.45-$8.85 (midpoint $8.65). Consensus is $8.75. In Q4, non-GAAP EPS of $1.86 compares to $1.90 in the year-ago period. Gilead ...
filo/iStock via Getty Images Although its Q4 2025 results beat on both lines, Gilead Sciences ( GILD ) is down ~4% in after-hours trading Tuesday after posting 2026 EPS guidance range with the midpoint below the consensus. The biopharma is predicting 2026 non-GAAP EPS of $8.45-$8.85 (midpoint $8.65). Consensus is $8.75. In Q4, non-GAAP EPS of $1.86 compares to $1.90 in the year-ago period. Gilead said the decline was due to higher acquired IPR&D expenses, though this was partially offset by higher product sales and lower SG&A expenses. Overall product sales increased 5% to ~$7.9B compared to Q4 2024. Sales in its biggest franchise, HIV medicines, increased 6% to ~$5.8B. Gilead ended 2025 with cash, cash equivalents, and marketable debt securities of $10.6B compared to $10B on Dec. 31, 2024. More on Gilead Sciences Gilead Sciences: Buy This Stock For Both Dividend And Growth Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) Gilead Sciences Non-GAAP EPS of $1.86 beats by $0.03, revenue of $7.93B beats by $250M Gilead Q4 preview: Core portfolio, Yeztugo launch keep analysts optimistic ahead of earnings
(RTTNews) - American International Group, Inc. (AIG) revealed a profit for fourth quarter that Drops, from the same period last year The company's earnings came in at $735 million, or $1.35 per share. This compares with $898 million, or $1.43 per share, last year. Excluding items, American International Group, Inc. reported adjusted earnings of $1.072 billion or $1.96 per share for the period. The...
(RTTNews) - American International Group, Inc. (AIG) revealed a profit for fourth quarter that Drops, from the same period last year The company's earnings came in at $735 million, or $1.35 per share. This compares with $898 million, or $1.43 per share, last year. Excluding items, American International Group, Inc. reported adjusted earnings of $1.072 billion or $1.96 per share for the period. The company's revenue for the period fell 0.6% to $6.039 billion from $6.077 billion last year. American International Group, Inc. earnings at a glance (GAAP) : -Earnings: $735 Mln. vs. $898 Mln. last year. -EPS: $1.35 vs. $1.43 last year. -Revenue: $6.039 Bln vs. $6.077 Bln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The rise of prediction markets is just the latest step of the institutionalization of the gambling world which continues to take professional gamblers away from traditional sports books. Bloomberg’s Ira Boudway has more. (Source: Bloomberg)
The rise of prediction markets is just the latest step of the institutionalization of the gambling world which continues to take professional gamblers away from traditional sports books. Bloomberg’s Ira Boudway has more. (Source: Bloomberg)